Home/Filings/4/0001104659-24-001495
4//SEC Filing

Gupta Suneel 4

Accession 0001104659-24-001495

CIK 0001377121other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:15 PM ET

Size

7.6 KB

Accession

0001104659-24-001495

Insider Transaction Report

Form 4
Period: 2024-01-02
Gupta Suneel
EVP Clinical Operations
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-02+71,50071,500 total
    Exercise: $23.42Exp: 2034-01-02Common Stock (71,500 underlying)
  • Award

    Common Stock

    2024-01-02+19,250187,567 total
Footnotes (2)
  • [F1]Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
  • [F2]The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1
  • filerCIK 0001763923

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:15 PM ET
Size
7.6 KB